Roald Skurtveit

Title: Roald Skurtveit: Innovator in Ultrasound Contrast Agents

Introduction

Roald Skurtveit is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of medical imaging, particularly in the development of ultrasound contrast agents. With a total of eight patents to his name, Skurtveit has established himself as a key figure in this innovative area.

Latest Patents

Among his latest patents, Skurtveit has developed ultrasound contrast agents that comprise microbubbles of biocompatible gas, such as a sulphur halide or a perfluorocarbon. These agents are stabilized by opsonisable amphiphilic materials, including membrane-forming lipids like phospholipids. Notably, negatively charged phospholipids, such as phosphatidylserine, may exhibit prolonged contrast-generating residence time in the liver following intravenous administration. Additionally, he has patented dry microparticles for use as contrast agents, which consist of gas or a gas precursor encapsulated by a non-polymeric and non-polymerisable wall-forming material. These microparticulate contrast agents are characterized by surprising structural integrity and stability.

Career Highlights

Throughout his career, Skurtveit has worked with prominent companies in the medical imaging sector, including Nycomed Imaging AS and GE Healthcare AS. His work has significantly advanced the capabilities of ultrasound imaging, providing healthcare professionals with improved tools for diagnosis.

Collaborations

Skurtveit has collaborated with notable colleagues, including Harald Dugstad and Jo Klaveness. These partnerships have contributed to the successful development and implementation of innovative imaging technologies.

Conclusion

Roald Skurtveit is a distinguished inventor whose work in ultrasound contrast agents has had a profound impact on medical imaging. His patents and collaborations reflect his commitment to advancing healthcare technology.